Sign up to access all features of our service.
  • Job search
  • Favorites
  • Create a CV
    New
  • Salaries
  • Subscriptions

Global Commercial Lead, Immunology & KT-621 Launch

Kymera Therapeutics

Kymera Therapeutics in Boston is seeking a strategic leader for the commercialization of KT-621, a novel protein degrader for immune-mediated diseases. This role involves shaping the global commercial strategy and ensuring successful launch readiness. The ideal candidate should possess 15+ years in pharmaceutical or biotechnology, particularly with immunological products. Kymera offers a competitive compensation range of $315,000 – $395,000 along with bonuses and equity participation. #J-18808-Ljbffr Kymera Therapeutics

Vacancy posted more than 2 months ago

Do you want to receive more vacancies?

Subscribe and receive similar vacancies to Global Commercial Lead, Immunology & KT-621 Launch. Be the first to apply!